From Bench to Bedside: Understanding the Critical Role of Biomarkers and Diagnostics in Unlocking the Potential of the Oncology Drugs Market.
The high price tag of modern oncology drugs is often attributed to the enormous, multi-billion-dollar R&D investment required, coupled with the high failure rate associated with clinical trials. However, as the market matures and competition intensifies—especially in therapeutic areas like breast and lung cancer where multiple targeted drugs are available—pressure is mounting...
0 Комментарии 0 Поделились 54 Просмотры 0 предпросмотр
JogaJog https://jogajog.com.bd